Next week, infectious disease clinicians and scientists will make their way to Washington, D.C. for the annual IDWeek conference, a meeting hosted by the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society.
The meeting, which will take place from Oct. 2 to 6, will feature a range of new data on HIV treatment and prevention, including safety updates on tenofovir alafenamide (TAF) versus tenofovir disoproxil fumarate (TDF), durability of oral cabotegravir, and efficacy of dolutegravir (DTG) plus lamivudine (3TC) as a two-drug regimen.
As always, the conference will summarize many of these findings across two popular sessions: "What's Hot in ID + HIV," which will be held on Oct. 2 -- the opening day of the conference -- and "HIV State-of-the-Art," which will take place the following day.
Vulnerable populations will once again be a major theme at IDWeek, with an entire session on Oct. 4 dedicated to "Populations with Disparities in the HIV Care Cascade."
This year, advocacy will be a strong theme throughout the IDWeek programming. Specifically, conference organizers have planned a Twitterstorm, calling on attendees to advocate for scientifically based vaccine strategies. The reason? Earlier this year, the World Health Organization declared vaccine hesitancy one of the greatest threats to human health.
Meanwhile, IDWeek is also making space for HIV providers who want to get political. In the wake of president Donald Trump's unexpected pledge earlier this year to end HIV in the United States by 2030, IDWeek will feature a special session called, "The Big IDea: Making the Case to Policymakers for ID and HIV Priorities" on Oct. 3.
"I encourage all of my colleagues to enjoy the discourse and exchange of information that takes place on IDWeek," said Anthony Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, speaking in a promotional video released by IDWeek staff.
Stay tuned here for TheBodyPro's coverage of late-breaking abstracts, interesting poster presentations, and curated symposia.